22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › BIO-TECHNE CORP. › 2024-2025

BIO-TECHNE CORP. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and BIO-TECHNE CORP.’s Form 8-K, filed October 30, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 12Ballot items
  • 606Asset managers, any item
  • 8,208Fund votes
  • October 24, 2024Meeting date

Results at a glance

Meeting of October 24, 2024: 12 items on BIO-TECHNE CORP.’s Form 8-K, filed October 30, 2024: 9 elected · 2 approved · 1 passed (calculated).

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIO-TECHNE CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by BIO-TECHNE CORP.

These tallies are BIO-TECHNE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed October 30, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIO-TECHNE CORP. — official shareholder meeting results, meeting held October 24, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
1. The shareholders voted to set the number of directors at nine 147,416,243587,153106,653 --0 99.6%Passed (calculated)—
Elect Director: Robert V. Baumgartner 135,629,6627,184,651108,555 --5,187,181 95%Elected—
Elect Director: Julie L. Bushman 137,726,8955,090,472105,501 --5,187,181 96%Elected—
Elect Director: John L. Higgins 135,544,8197,264,115113,934 --5,187,181 95%Elected—
Elect Director: Roeland Nusse 141,573,2451,241,096108,527 --5,187,181 99.1%Elected—
Elect Director: Kim Kelderman 142,088,978730,531103,359 --5,187,181 99.5%Elected—
Elect Director: Joseph D. Keegan 139,194,2513,617,533111,084 --5,187,181 97%Elected—
Elect Director: Alpna Seth 137,509,6355,302,948110,285 --5,187,181 96%Elected—
Elect Director: Rupert Vessey 140,985,8431,825,907111,118 --5,187,181 99%Elected—
Elect Director: Judith Klimovsky 142,641,977176,715104,176 --5,187,181 99.9%Elected—
3. Non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement 122,860,46419,912,153150,251 --5,187,181 86%Approved—
4. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025 34,862,262856,4805,701 --0 98%Approved—

Source: BIO-TECHNE CORP., Form 8-K, filed with the SEC on October 30, 2024 — read the filing on EDGAR.

How asset managers voted at the BIO-TECHNE CORP. 2024-2025 meeting

606 asset managers disclosed a vote on at least one BIO-TECHNE CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Alpna Seth

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 137,509,635AGAINST: 5,302,948

Prior year: 95.0% for (October 26, 2023 meeting) ▲ 1.3 pts

Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Alpna Seth

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Alpna Seth”): 137,509,635 for, 5,302,948 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Alpna Seth” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,249,7221,523 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,362131 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon66,843517,367 00Mixed
ALGER FUNDS0569,146 00Against
Lincoln Financial545,5739,074 00For
Dimensional0547,037 00Against
Nationwide498,25911,382 00For

Fund voting reports, all 136 managers: 74,019,538 for, 1,927,406 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Alpna Seth” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC800 00For
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,442 for.

Elect Director: John L. Higgins

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 135,544,819AGAINST: 7,264,115

Prior year: 82.5% for (October 26, 2023 meeting) ▲ 12.5 pts

Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: John L. Higgins

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: John L. Higgins”): 135,544,819 for, 7,264,115 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: John L. Higgins” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,249,7221,523 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,329164 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust707,203100,173 00Mixed
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS0569,146 00Against
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,125,616 for, 821,328 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: John L. Higgins” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC080 00Against
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,362 for, 80 against.

Elect Director: Joseph D. Keegan

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 139,194,251AGAINST: 3,617,533

Prior year: 94.8% for (October 26, 2023 meeting) ▲ 2.7 pts

Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Joseph D. Keegan

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Joseph D. Keegan”): 139,194,251 for, 3,617,533 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Joseph D. Keegan” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,249,7221,523 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,362131 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS0569,146 00Against
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,248,711 for, 698,233 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Joseph D. Keegan” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC080 00Against
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,362 for, 80 against.

Elect Director: Judith Klimovsky

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 142,641,977AGAINST: 176,715
Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Judith Klimovsky

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Judith Klimovsky”): 142,641,977 for, 176,715 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Judith Klimovsky” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,251,2450 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,4930 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,946,531 for, 413 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Judith Klimovsky” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC800 00For
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,442 for.

Elect Director: Julie L. Bushman

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 137,726,895AGAINST: 5,090,472

Prior year: 93.2% for (October 26, 2023 meeting) ▲ 3.2 pts

Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Julie L. Bushman

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Julie L. Bushman”): 137,726,895 for, 5,090,472 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Julie L. Bushman” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,250,727518 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,45340 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,927,548 for, 19,396 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Julie L. Bushman” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.0855,881 00Against
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC080 00Against
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 22,481 for, 855,961 against.

Elect Director: Kim Kelderman

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 142,088,978AGAINST: 730,531
Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Kim Kelderman

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Kim Kelderman”): 142,088,978 for, 730,531 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Kim Kelderman” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,251,2450 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,4867 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,946,524 for, 420 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Kim Kelderman” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC800 00For
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,442 for.

Elect Director: Robert V. Baumgartner

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 135,629,662AGAINST: 7,184,651

Prior year: 70.6% for (October 26, 2023 meeting) ▲ 24.4 pts

Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Robert V. Baumgartner

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Robert V. Baumgartner”): 135,629,662 for, 7,184,651 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Robert V. Baumgartner” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,250,1691,076 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,42073 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust707,203100,173 00Mixed
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,837,176 for, 109,768 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Robert V. Baumgartner” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC080 00Against
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,362 for, 80 against.

Elect Director: Roeland Nusse

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 141,573,245AGAINST: 1,241,096

Prior year: 96.2% for (October 26, 2023 meeting) ▲ 2.9 pts

Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Roeland Nusse

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Roeland Nusse”): 141,573,245 for, 1,241,096 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Roeland Nusse” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,250,727518 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,44548 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,945,867 for, 1,077 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Roeland Nusse” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC800 00For
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,442 for.

Elect Director: Rupert Vessey

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 140,985,843AGAINST: 1,825,907

Prior year: 94.8% for (October 26, 2023 meeting) ▲ 3.9 pts

Details: description as filed, official tally, votes by 141 asset managers

Description as filed by funds: Election of Directors: Rupert Vessey

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Rupert Vessey”): 140,985,843 for, 1,825,907 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Election of Directors: Rupert Vessey” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,250,727518 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,45340 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 136 managers: 75,945,874 for, 1,070 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “Election of Directors: Rupert Vessey” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.12,6770 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC080 00Against
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 878,362 for, 80 against.

The shareholders voted to set the number of directors at nine

Calculated outcomeFund totals may overlapAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 147,416,243AGAINST: 587,153
Details: description as filed, official tally, votes by 139 asset managers

Description as filed by funds: To set the number of Directors at nine.

BIO-TECHNE CORP.’s own tally for this item (“1. The shareholders voted to set the number of directors at nine”): 147,416,243 for, 587,153 against, per its Form 8-K filed October 30, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIO-TECHNE CORP.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Fix Number of Directors” (2 managers, 45,462 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 135 asset managers voting on “To set the number of Directors at nine.” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,251,2450 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,4930 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 135 managers: 75,944,582 for, 413 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 4 asset managers voting on “To set the number of Directors at nine.” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC800 00For
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 4 managers: 865,765 for.

Non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

86% Approved · of votes cast

FOR 86%
FOR: 122,860,464AGAINST: 19,912,153

Prior year: 35.3% for (October 26, 2023 meeting) ▲ 50.7 pts

Details: description as filed, official tally, votes by 566 asset managers

Description as filed by funds: Approve, on an advisory basis, the compensation of our executive officers.

BIO-TECHNE CORP.’s own tally for this item (“3. A non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement”): 122,860,464 for, 19,912,153 against — passed, per its Form 8-K filed October 30, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 – The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIO-TECHNE CORP.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION” (20 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “14A Executive Compensation” (9 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Approve, on an advisory basis, the H of our executive officers.” (2 managers, 228,589 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 133 asset managers voting on “Approve, on an advisory basis, the compensation of our executive officers.” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,249,1642,081 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco02,634,533 00Against
Columbia Threadneedle02,302,872 00Against
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,645,2943,151 00For
State Street1,581,329164 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust707,203100,173 00Mixed
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS0569,146 00Against
Lincoln Financial515,79138,856 00Mixed
Dimensional547,0370 00For
Nationwide509,6410 00For

Fund voting reports, all 133 managers: 69,122,581 for, 6,482,104 against, 8,087 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 468 asset managers voting on “Approve, on an advisory basis, the compensation of our executive officers.” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price10,017,6950 00For
BlackRock4,769,84548,612 00For
BAMCO INC /NY/4,193,6730 00For
GEODE CAPITAL MANAGEMENT, LLC3,903,1490 00For
State Street3,715,49870,301 00For
Neuberger Berman3,510,1020 00For
DF DENT & CO INC3,113,0040 00For
MACKENZIE FINANCIAL CORP2,855,2030 00For
Invesco02,837,572 00Against
ATLANTA CAPITAL MANAGEMENT CO L L C2,797,12634,698 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2,640,3420 00For
Select Equity Group, L.P.1,899,0720 00For
MARSHALL WACE, LLP01,623,386 00Against
Charles Schwab1,519,6990 00For
AMERIPRISE FINANCIAL INC31,5951,400,073 00Against
Wellington1,404,3380 00For
Northern Trust1,327,03642,547 00For
Fidelity1,317,5130 00For
BROWN CAPITAL MANAGEMENT LLC1,223,8900 00For
Nikko Asset Management Co., Ltd.1,031,6540 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1,028,8420 00For
GENEVA CAPITAL MANAGEMENT LLC1,016,0280 00For
BROWN ADVISORY INC1,015,224610 00For
SNYDER CAPITAL MANAGEMENT L P1,005,1460 00For
Clearbridge Investments, LLC977,2150 00For

Institutional-manager reports, all 468 managers: 77,261,567 for, 11,160,263 against, 14,897 abstained, 14,611 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending…

Official resultFund totals may overlapAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 34,862,262AGAINST: 856,480

Prior year: 96.4% for (October 26, 2023 meeting) ▲ 1.2 pts

Details: description as filed, official tally, votes by 143 asset managers

Description as filed by funds: RATIFY THE APPOINTMENT OF KPMG, LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2025 FISCAL YEAR.

BIO-TECHNE CORP.’s own tally for this item (“4. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025”): 34,862,262 for, 856,480 against — passed, per its Form 8-K filed October 30, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 4 – The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 138 asset managers voting on “RATIFY THE APPOINTMENT OF KPMG, LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 202” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,947,4040 00For
T. Rowe Price7,143,7440 00For
BlackRock5,251,2450 00For
Fidelity4,800,7200 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)3,759,9440 00For
Invesco2,634,5330 00For
Columbia Threadneedle2,302,8720 00For
Neuberger Berman2,253,2370 00For
Eaton Vance2,186,2170 00For
MFS1,963,5560 00For
Waddell & Reed1,742,7640 00For
TRUST FOR PROFESSIONAL MANAGERS1,648,4450 00For
State Street1,581,46132 00For
Charles Schwab1,489,9650 00For
Advisors' Inner Circle Fund II1,261,7550 00For
JANUS INVESTMENT FUND872,4110 00For
Brown Capital Management Mutual Funds861,6430 00For
Bridge Builder Trust807,3760 00For
Hartford759,4230 00For
Royce629,7930 00For
BNY Mellon584,2100 00For
ALGER FUNDS569,1460 00For
Lincoln Financial554,6470 00For
Dimensional547,0370 00For
Nationwide509,6410 00For

No total is shown for the fund voting reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “RATIFY THE APPOINTMENT OF KPMG, LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 202” at BIO-TECHNE CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.855,8810 00For
Cardano Risk Management B.V.012,677 00Against
L. Roy Papp & Associates, LLP9,7300 00For
apricus wealth, LLC080 00Against
Portside Wealth Group, LLC740 00For

Institutional-manager reports, all 5 managers: 865,685 for, 12,757 against.

Largest BIO-TECHNE CORP. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 158,878,127 shares outstanding at the time of that meeting.

Fund voting reports: top BIO-TECHNE CORP. shareholders by shares voted on “RATIFY THE APPOINTMENT OF KPMG, LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 11.93%
2T. Rowe Price 4.50%
3BlackRock 3.31%
4Fidelity 3.02%
5BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) 2.37%
6Invesco 1.66%
7Columbia Threadneedle 1.45%
8Neuberger Berman 1.42%
9Eaton Vance 1.38%
10MFS 1.24%
Institutional-manager reports: top BIO-TECHNE CORP. shareholders by shares voted on “Approve, on an advisory basis, the compensation of our executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1T. Rowe Price 6.31%
2BlackRock 3.03%
3BAMCO INC /NY/ 2.64%
4GEODE CAPITAL MANAGEMENT, LLC 2.46%
5State Street 2.38%
6Neuberger Berman 2.21%
7DF DENT & CO INC 1.96%
8MACKENZIE FINANCIAL CORP 1.80%
9Invesco 1.79%
10ATLANTA CAPITAL MANAGEMENT CO L L C 1.78%

Reported BIO-TECHNE CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

BIO-TECHNE CORP. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vanguard Group18,526,824 11.66%Form 13F, quarter ended March 31, 2025
Malvern, PA18,397,700 11.58%Proxy statement (DEF 14A), proxy filed September 19, 2025
BlackRock13,746,351 8.65%Form 13F, quarter ended March 31, 2025
New York, NY11,964,228 7.53%Proxy statement (DEF 14A), proxy filed September 19, 2025
T. Rowe Price11,375,279 7.16%Form 13F, quarter ended March 31, 2025
Baltimore, MD10,163,026 6.40%Proxy statement (DEF 14A), proxy filed September 19, 2025
FMR LLC7,859,928 4.95%Schedule 13G, filed May 6, 2026
State Street6,529,887 4.11%Form 13F, quarter ended March 31, 2025
Morgan Stanley5,719,540 3.60%Form 13F, quarter ended March 31, 2025
Invesco4,190,115 2.64%Form 13F, quarter ended March 31, 2025

Percentages above are of 158,878,127 shares outstanding, as reported by BIO-TECHNE CORP. on its Form 10-Q dated September 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At BIO-TECHNE CORP.'s shareholder meeting held October 24, 2024, in the 2024-2025 proxy season, 606 asset managers reported votes on at least one of its 12 ballot items in their SEC Form N-PX filings, covering 8,208 separate fund positions. On the most widely held item on that ballot — Approve, on an advisory basis, the compensation of our executive officers. — BIO-TECHNE CORP.'s filing reports the proposal as approved, with 86% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BIO-TECHNE CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on October 30, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIO-TECHNE CORP.’s 10-Q dated September 30, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

BIO-TECHNE CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “BIO-TECHNE (TECH) 2024 Annual Meeting (2024-2025 season): Vote Results”, https://proxyvotesnow.com/company/bio-techne-corp/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.